Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Positron-Emission Tomography | 30 | 2016 | 6485 | 1.250 |
Why?
|
| Image Interpretation, Computer-Assisted | 13 | 2015 | 3359 | 0.990 |
Why?
|
| Image Processing, Computer-Assisted | 14 | 2016 | 9002 | 0.860 |
Why?
|
| Image Enhancement | 8 | 2014 | 2885 | 0.540 |
Why?
|
| Algorithms | 19 | 2015 | 14032 | 0.460 |
Why?
|
| Phantoms, Imaging | 17 | 2015 | 2526 | 0.370 |
Why?
|
| Evaluation Studies as Topic | 1 | 2013 | 1624 | 0.370 |
Why?
|
| Models, Biological | 8 | 2016 | 9469 | 0.360 |
Why?
|
| Pattern Recognition, Automated | 2 | 2014 | 997 | 0.350 |
Why?
|
| Fluorodeoxyglucose F18 | 10 | 2016 | 2010 | 0.340 |
Why?
|
| Models, Neurological | 2 | 2015 | 1769 | 0.330 |
Why?
|
| Fourier Analysis | 6 | 2015 | 441 | 0.320 |
Why?
|
| Brain | 10 | 2015 | 27120 | 0.320 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2014 | 4063 | 0.310 |
Why?
|
| Subtraction Technique | 2 | 2010 | 512 | 0.300 |
Why?
|
| Models, Statistical | 4 | 2013 | 5079 | 0.280 |
Why?
|
| Molecular Imaging | 1 | 2013 | 815 | 0.270 |
Why?
|
| Regression Analysis | 2 | 2015 | 6344 | 0.270 |
Why?
|
| Information Storage and Retrieval | 2 | 2007 | 819 | 0.230 |
Why?
|
| Respiratory-Gated Imaging Techniques | 2 | 2015 | 75 | 0.230 |
Why?
|
| Alzheimer Disease | 2 | 2015 | 8601 | 0.220 |
Why?
|
| Whole Body Imaging | 3 | 2015 | 283 | 0.220 |
Why?
|
| Quality Assurance, Health Care | 1 | 2013 | 2169 | 0.210 |
Why?
|
| Nerve Net | 1 | 2014 | 2291 | 0.190 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 1122 | 0.190 |
Why?
|
| Monte Carlo Method | 6 | 2016 | 1258 | 0.180 |
Why?
|
| Brain Mapping | 1 | 2015 | 6635 | 0.170 |
Why?
|
| Radiopharmaceuticals | 8 | 2016 | 2651 | 0.170 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2013 | 485 | 0.170 |
Why?
|
| Normal Distribution | 3 | 2016 | 272 | 0.160 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3708 | 0.150 |
Why?
|
| Sensitivity and Specificity | 10 | 2014 | 14666 | 0.150 |
Why?
|
| Movement | 2 | 2014 | 1479 | 0.130 |
Why?
|
| Reproducibility of Results | 11 | 2015 | 20099 | 0.130 |
Why?
|
| Computer Simulation | 7 | 2016 | 6241 | 0.130 |
Why?
|
| Pyrrolidines | 3 | 2013 | 338 | 0.120 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2014 | 143 | 0.120 |
Why?
|
| Poisson Distribution | 1 | 2014 | 504 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2015 | 36429 | 0.110 |
Why?
|
| Neostriatum | 1 | 2013 | 247 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 20571 | 0.100 |
Why?
|
| Peptides, Cyclic | 1 | 2013 | 392 | 0.100 |
Why?
|
| Benzamides | 3 | 2013 | 1370 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2009 | 1496 | 0.090 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2010 | 122 | 0.090 |
Why?
|
| Models, Theoretical | 2 | 2015 | 3575 | 0.090 |
Why?
|
| Aniline Compounds | 1 | 2015 | 1069 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2013 | 1187 | 0.080 |
Why?
|
| Liver Neoplasms | 2 | 2014 | 4319 | 0.070 |
Why?
|
| Reference Values | 1 | 2015 | 4920 | 0.070 |
Why?
|
| Parkinson Disease | 2 | 2013 | 2877 | 0.070 |
Why?
|
| Thiazoles | 1 | 2015 | 1517 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6228 | 0.070 |
Why?
|
| Automation | 1 | 2010 | 586 | 0.070 |
Why?
|
| Physical Conditioning, Animal | 1 | 2010 | 365 | 0.070 |
Why?
|
| Kinetics | 4 | 2016 | 6374 | 0.070 |
Why?
|
| Exercise Therapy | 1 | 2013 | 929 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 2047 | 0.060 |
Why?
|
| Whole-Body Counting | 1 | 2004 | 36 | 0.060 |
Why?
|
| Corpus Striatum | 1 | 2010 | 1235 | 0.060 |
Why?
|
| Likelihood Functions | 1 | 2006 | 992 | 0.050 |
Why?
|
| Humans | 23 | 2016 | 761572 | 0.050 |
Why?
|
| Sarcoma | 1 | 2014 | 1801 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 3530 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2015 | 3839 | 0.050 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 847 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 2538 | 0.050 |
Why?
|
| Motion | 2 | 2015 | 779 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 2297 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2015 | 3482 | 0.040 |
Why?
|
| Heart | 1 | 2013 | 4404 | 0.040 |
Why?
|
| Animals | 11 | 2015 | 168467 | 0.040 |
Why?
|
| Mice | 6 | 2015 | 81533 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2014 | 3408 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2015 | 3614 | 0.040 |
Why?
|
| Respiration | 2 | 2015 | 1657 | 0.040 |
Why?
|
| Numerical Analysis, Computer-Assisted | 2 | 2007 | 119 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 2691 | 0.030 |
Why?
|
| Lung | 1 | 2015 | 10002 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2016 | 369 | 0.030 |
Why?
|
| Macaca | 2 | 2007 | 410 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 2016 | 320 | 0.030 |
Why?
|
| Electric Power Supplies | 1 | 2015 | 96 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 9031 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 2015 | 490 | 0.030 |
Why?
|
| Time Factors | 3 | 2014 | 39970 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 5779 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 2013 | 361 | 0.030 |
Why?
|
| Markov Chains | 1 | 2016 | 966 | 0.030 |
Why?
|
| Neoplasms | 2 | 2013 | 22173 | 0.030 |
Why?
|
| Male | 6 | 2015 | 360842 | 0.020 |
Why?
|
| Neurons | 1 | 2010 | 9463 | 0.020 |
Why?
|
| ROC Curve | 2 | 2009 | 3579 | 0.020 |
Why?
|
| Calibration | 1 | 2014 | 818 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2006 | 7967 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 13382 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2010 | 89 | 0.020 |
Why?
|
| Safety | 1 | 2015 | 1150 | 0.020 |
Why?
|
| Albumins | 1 | 2013 | 575 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 59255 | 0.020 |
Why?
|
| Female | 8 | 2015 | 392686 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 64684 | 0.020 |
Why?
|
| Posture | 1 | 2013 | 957 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2016 | 2330 | 0.020 |
Why?
|
| Data Compression | 1 | 2009 | 69 | 0.020 |
Why?
|
| Aged | 3 | 2015 | 169310 | 0.020 |
Why?
|
| Gait | 1 | 2013 | 814 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2009 | 957 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2013 | 2224 | 0.020 |
Why?
|
| Artifacts | 1 | 2015 | 1911 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2013 | 1732 | 0.020 |
Why?
|
| Child | 1 | 2014 | 80156 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 88324 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 1882 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2013 | 1436 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 3492 | 0.010 |
Why?
|
| Probability | 1 | 2010 | 2477 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2014 | 1909 | 0.010 |
Why?
|
| Miniaturization | 1 | 2004 | 153 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2010 | 5035 | 0.010 |
Why?
|
| Contrast Media | 1 | 2013 | 5311 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2013 | 8633 | 0.010 |
Why?
|
| Breast | 1 | 2009 | 1967 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 16986 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 12059 | 0.010 |
Why?
|
| Equipment Design | 1 | 2004 | 3511 | 0.010 |
Why?
|
| Middle Aged | 3 | 2015 | 220920 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2004 | 2568 | 0.010 |
Why?
|
| Glucose | 1 | 2004 | 4346 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 22172 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2009 | 21017 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13642 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 23741 | 0.000 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_